Perspective Therapeutics (CATX) Return on Capital Employed Growth (3y) (2016 - 2026)
Perspective Therapeutics (CATX) Return on Capital Employed Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 370.00 |
| 10 | Perspective Therapeutics | 386.32 Mn | 386.32 Mn | - | -491.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 89,047.00 |
| Mar 31, 2026 | 105,721.00 |
| Dec 31, 2025 | 128,499.00 |
| Sep 30, 2025 | -1,542.00 |
| Jun 30, 2025 | -2,038.00 |
| Mar 31, 2025 | -2,483.00 |
| Dec 31, 2024 | -2,109.00 |
| Sep 30, 2024 | -1,219.00 |
| Jun 30, 2024 | -1,369.00 |
| Mar 31, 2024 | -1,692.00 |
| Dec 31, 2023 | -1,438.00 |
| Sep 30, 2023 | 1,650.00 |
| Jun 30, 2023 | 1,944.00 |
| Mar 31, 2023 | 1,664.00 |
| Dec 31, 2022 | 1,764.00 |
| Sep 30, 2022 | 3,255.00 |
| Jun 30, 2022 | 4,526.00 |
| Mar 31, 2022 | 5,944.00 |
| Dec 31, 2021 | 5,554.00 |
| Sep 30, 2021 | 7,262.00 |